The regulatory agency will review MSD’s new drug application (NDA) for Welireg under a Priority Review, with a Prescription ...

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance ...

The UK biotech sector raised £3.5bn in 2024, the highest annual total since 2021 when £4.5bn was raised. The UK biotech ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North ...

The financial challenges facing clinical trials have created a more risk-averse landscape. Yet digital solutions could be the key for sponsors and CROs to optimize budgets and resources. We explore ...

The FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for ...

The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.